<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005172</url>
  </required_header>
  <id_info>
    <org_study_id>506493-2</org_study_id>
    <nct_id>NCT02005172</nct_id>
  </id_info>
  <brief_title>Validation of an iPhone-based Event Recorder for Arrhythmia Detection</brief_title>
  <official_title>Validation of an iPhone-based Event Recorder for Arrhythmia Detection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University at Buffalo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University at Buffalo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will evaluate the diagnostic yield of the new AliveCor device versus a 14
      day event monitor with the use of both devices simultaneously. We will also examine by means
      of a questionnaire the compliance, ease of use and patient satisfaction for each device.

      Hypothesis:

        1. The AliveCor monitor will be non-inferior to the 14 day event monitor with respect to
           diagnosis of the arrhythmia responsible for a patient's symptoms.

        2. The AliveCor monitor will have better compliance and acceptability compared to the 14
           day event monitor, and thus there will be a greater number of days with recordings from
           the AliveCor monitor.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of an iPhone-based Event Recorder for Arrhythmia Detection</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Arrhythmia, Palpitations, Lightheadedness</condition>
  <arm_group>
    <arm_group_label>Alivecor device and event monitor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Both the Alivecor device (experimental) and the standard of care (event monitor) will be provided to all patients for the duration of the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alivecor monitor and 14 day event monitor</intervention_name>
    <description>Alivecor monitor and 14 day event monitor</description>
    <arm_group_label>Alivecor device and event monitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients &gt;18 years of age with symptoms such as palpitations or pre-syncope suggestive of
        arrhythmias (usually occurring less frequently than once a day) with prior non-diagnostic
        ECGs and/or Holter monitoring.

        Patients who own an iPhone 4, 4S or 5 device and demonstrate the capability of recording
        and uploading a test ECG recording at the office visit.

        Exclusion Criteria:

          1. Patients &lt;18 years of age.

          2. Patients with a myocardial infarction (MI) within the last three months, and/or known
             history of sustained VT/VF.

          3. Patients with NYHA class IV heart failure.

          4. Patients with unstable angina.

          5. Patients with syncope as the presenting symptom.

          6. Patients unable to or unwilling to use the device.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Curtis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University at Buffalo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deepika Narasimha, MD</last_name>
    <email>deepikan@buffalo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susan Danzer, RN</last_name>
    <phone>716 961 9900</phone>
    <email>susandan@buffalo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dent Towers</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Danzer, RN</last_name>
      <phone>716-991-9900</phone>
      <email>susandan@buffalo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Deepika Narasimha, MD</last_name>
      <email>deepikan@buffalo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anne Curtis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deepika Narasimha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2013</study_first_submitted>
  <study_first_submitted_qc>December 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University at Buffalo</investigator_affiliation>
    <investigator_full_name>Deepika Narasimha</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>arrhythmia, palpitations, lightheadedness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dizziness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

